<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01949129</url>
  </required_header>
  <id_info>
    <org_study_id>ALL SCTped FORUM 2012</org_study_id>
    <nct_id>NCT01949129</nct_id>
  </id_info>
  <brief_title>Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia</brief_title>
  <official_title>Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Anna Kinderkrebsforschung</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>ALL SCTped Forum</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>St. Anna Kinderkrebsforschung</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The ALL SCTped 2012 FORUM is a multinational, multi-centre, controlled, prospective phase III
      study for the therapy and therapy optimisation for children and adolescents with ALL in
      complete morphological remission (CR, less than 5% bone marrow blasts, no blasts in
      cerebrospinal fluid, no other extramedullary leukemia), who have an indication for HSCT with
      a myeloablative conditioning regimen.

      The stratification of patients in first and following remissions according to the individual
      transplantation modalities rests upon an indication for allogeneic HSCT and the availability
      of a suitable donor within the individual transplantation groups.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Acute and late side effects of TBI in combination with other chemotherapeutic are manifold to
      the growing organism and include severe organ dysfunction/failure due to toxicity. Although
      transplant associated mortality was reduced after HSCT in the last decade due to better HLA
      matching, infection prevention and control, the burden of late complications is still a
      matter of concern. Growth retardation, hormonal dysfunction, sterility and the risk of
      secondary cancer are the late consequences of TBI in children. However, so far no prospective
      study has demonstrated similar outcomes in paediatric ALL using chemo-conditioning regimen
      before HSCT. The reason for that is manifold: only a minority of children with ALL qualifies
      for allogeneic HSCT as most patients are cured with sole modern chemotherapy approaches.
      Those with dismal prognosis are treated in HSCT centres offering a care to patients with
      different diseases. Therefore it is nearly impossible to answer the complex outcome questions
      in single centres or even in single countries. International cooperation is essential to
      allow prospective investigation within comparable patient cohorts.

      This study aimed to explore the efficacy and efficiency of two different chemo-conditioning
      regimens (Flu/Thio with Treo or ivBu) in comparison to the standard conditioning regimen
      (TBI/VP16). All patients with an indication for HSCT, age &gt; 4 years and a matched donor (MD)
      or matched sibling donor (MSD) underwent a randomisation between these two conditioning
      regimens. The decision if the irradiation free conditioning is Flu/Thio/Treo or Flu/Thio/ivBu
      was stratified by country. Patients with age &lt; 4 years received the irradiation free
      conditioning. Patients with a mismatched donor were stratified according to the donor's stem
      cell source (cordblood, haploidentical tx or bone marrow/peripheral blood stem cells).

      After an interim analysis of the randomized FORUM-trial in December 2018, which showed
      superior OS for TBI/Etoposide with equal outcomes for Bu or Treo-containing regimen, the
      randomization was suspended. The reason was less relapse incidence whereas 1-year TRM was
      comparable in all 3 arms. The randomization was closed in March 2019 based on the results of
      additional analyses confirming the superiority of TBI/VP16 over chemo-conditioning.
      Consequently, the TBI conditioning has remained a standard for the patients older than 4
      years with a MSD/MD. Use of a conditioning other than TBI/VP16 in this age group is made at
      the center level based on the assessment of each individual patient.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Anticipated">April 2026</completion_date>
  <primary_completion_date type="Anticipated">April 2021</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Overall Survival (OS) Stratum 1a (randomisation TBI+ chemo-conditioning vs. chemo-conditioning only)</measure>
    <time_frame>first: 18 months after inclusion of first patient, afterwards annually up to 10 years</time_frame>
    <description>Stratum 1 - randomisation related question was closed in December 2018; patients are in active follow-up: To show that a non total body irradiation (TBI) containing conditioning (Flu/Thio/ivBu or Flu/Thio/Treo) results in a non-inferior survival as compared to conditioning with TBI/Etoposide in children older than 4 years after HSCT from a Human leucocyte antigen (HLA) identical sibling donor (MSD) or a HLA matched donor (MD). The primary endpoint is the OS calculated from the date of the randomisation. Death from any cause will be considered an event.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Event free survival (EFS) Stratum 2 (mismatched donor transplantation)</measure>
    <time_frame>first: 18 months after inclusion of first patient, afterwards annually up to 10 years</time_frame>
    <description>EFS after allogeneic HSCT. EFS calculated from date of recruitment to disease progression or relapse, secondary neoplasm and death from any cause.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Overall Survival (OS), Stratum 1b: MSD/MD without randomisation</measure>
    <time_frame>first: 18 months after inclusion of first patient, afterwards annually up to 10 years</time_frame>
    <description>To explore the impact of risk factors on the incidence of adverse events of special interest (AESIs) and on overall survival and event free survival in the entire MSD/MD cohort</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>EFS (Stratum 1a and 1b)</measure>
    <time_frame>first: 18 months after inclusion of first patient, afterwards annually up to 10 years</time_frame>
    <description>EFS calculated from date of randomization (1a) or recruitment (1b) to disease progression or relapse, secondary neoplasm and death from any cause. Patients lost to follow-up without event will be censored at the date of their last follow-up evaluation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>TRM</measure>
    <time_frame>first: 18 months after inclusion of first patient, afterwards annually up to 10 years</time_frame>
    <description>Cumulative Incidence of Treatment-related mortality (TRM) for Stratum 1 and 2.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Relapse/progression</measure>
    <time_frame>first: 18 months after inclusion of first patient, afterwards annually up to 10 years</time_frame>
    <description>Cumulative Incidence of Relapse for Stratum 1a, 1b and 2.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Acute and late toxicity for Stratum 1a, 1b and 2</measure>
    <time_frame>first: 18 months after inclusion of first patient, afterwards annually up to 10 years</time_frame>
    <description>according a preselection out of CTC3</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>OS (Stratum 2)</measure>
    <time_frame>first: 18 months after inclusion of first patient, afterwards annually up to 10 years</time_frame>
    <description>The primary endpoint is the OS calculated from the date of the recruitment . Death from any cause will be considered an event.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Acute Graft versus Host Disease (aGVHD)</measure>
    <time_frame>first: 18 months after inclusion of first patient, afterwards annually up to 10 years</time_frame>
    <description>According to the modified Seattle Glucksberg criteria</description>
  </other_outcome>
  <other_outcome>
    <measure>Secondary malignancies</measure>
    <time_frame>first: 18 months after inclusion of first patient, afterwards annually up to 10 years</time_frame>
    <description>Incidence, type and timepoint of occurence</description>
  </other_outcome>
  <other_outcome>
    <measure>Chronic Graft-versus-host disease (cGvHD)</measure>
    <time_frame>first: 18 months after inclusion of first patient, afterwards annually up to 10 years</time_frame>
    <description>Chronic GVHD is diagnosed using criteria created through the NIH consensus development project</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Acute Lymphoblastic Leukaemia</condition>
  <arm_group>
    <arm_group_label>Flu/Thio/Treo</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Fludarabine/Thiotepa/Treosulfan is for conditioning before HSCT from MSD or MD. ATG Thymo or Grafalon is used for patients who receive stem cells from unrelated donors.
Fludarabine/Thiotepa/Treosulfan with either ATG Thymo or Grafalon is also used for HSCT from MMD with in vitro T-Cell Depletion (TCD) or with CD34+ selection.
Fludarabine/Thiotepa/Treosulfan with Post Tx-Cyclophosphamide is used for MMD-graft without in vitro TCD.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TBI/VP16</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>TBI (Total Body Irradiation) / VP16 is used for conditioning for HSCT with MSD or MD graft with patients who are older than 48 months at the time of conditioning.
TBI/VP16 is also used with Post TX-Cyclophosphamide for MMD-graft without in vitro T-Cell Depletion.
TBI/VP16 with either ATG Thymo or Grafalon is used for MMD-HSCT with in vitro T-Cell Depletion or with CD34+ selection.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Flu/Thio/ivBu</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Fludarabine/Thiotepa/iV Busulfan is used for conditioning before HSCT from MSD or MD.
Fludarabine/Thiotepa/iBu with either ATG Thymo or Grafalon is also used for HSCT from MMD-HSCT with T-Cell Depletion (TCD) or haplo with CD34+ selection.
Fludarabine/Thiotepa/iV Busulfan with Post Tx-Cyclophosphamide is used for MMD-graft without in vitro TCD.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>VP16</intervention_name>
    <description>60 mg/kg BW,1 day</description>
    <arm_group_label>TBI/VP16</arm_group_label>
    <other_name>Etoposide</other_name>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>TBI</intervention_name>
    <description>2 x 2Gy/day , 3 days (total 12Gy)</description>
    <arm_group_label>TBI/VP16</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Thiotepa</intervention_name>
    <description>2x5 mg/kg BW, 1 day</description>
    <arm_group_label>Flu/Thio/Treo</arm_group_label>
    <arm_group_label>Flu/Thio/ivBu</arm_group_label>
    <other_name>Thio</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Treosulfan</intervention_name>
    <description>14g/m² BS, 3 days</description>
    <arm_group_label>Flu/Thio/Treo</arm_group_label>
    <other_name>Treo</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fludarabine</intervention_name>
    <description>30 mg/m² BS, 5 days</description>
    <arm_group_label>Flu/Thio/Treo</arm_group_label>
    <arm_group_label>Flu/Thio/ivBu</arm_group_label>
    <other_name>Flu</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Busulfan</intervention_name>
    <description>iV, dosage according therapeutic drug monitoring, 4 days</description>
    <arm_group_label>Flu/Thio/ivBu</arm_group_label>
    <other_name>Bu</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ATG Thymoglobulin</intervention_name>
    <description>MD: ATG Thymo: 2,5mg/kg BW/d 3 days.</description>
    <arm_group_label>Flu/Thio/Treo</arm_group_label>
    <arm_group_label>Flu/Thio/ivBu</arm_group_label>
    <arm_group_label>TBI/VP16</arm_group_label>
    <other_name>ATG Thymo</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cyclophosphamide</intervention_name>
    <description>50mg/kg BW/d 2 days with Mesna</description>
    <arm_group_label>Flu/Thio/ivBu</arm_group_label>
    <other_name>Cy</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Grafalon</intervention_name>
    <description>MD: 15mg/kg BW/d 3 days MMD: 10mg/kg BW/d 3 days</description>
    <arm_group_label>Flu/Thio/Treo</arm_group_label>
    <arm_group_label>Flu/Thio/ivBu</arm_group_label>
    <arm_group_label>TBI/VP16</arm_group_label>
    <other_name>Anti-human T-lymphocyte immunoglobulin</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patients with ALL (except for patients with B-ALL) who fulfil the following criteria:

          -  age at diagnosis ≤ 18 years. Age at HSCT ≤ 21 years

          -  indication for allogeneic HSCT

          -  complete remission (CR) before HSCT

          -  written consent of the parents (legal guardian) and, if necessary, the minor patient
             via &quot;Informed Consent Form&quot;

          -  no pregnancy

          -  no secondary malignancy

          -  no previous HSCT

          -  HSCT is performed in a study participating centre

        Exclusion Criteria:

          -  patients who do not fulfil the inclusion criteria

          -  Non Hodgkin-Lymphoma

          -  the whole protocol or essential parts are declined either by patient himself/herself
             or the respective legal guardian

          -  no consent is given for saving and propagation of anonymous medical data for study
             reasons

          -  severe concomitant disease that does not allow treatment according to the protocol at
             the investigator's discretion (e.g. malformation syndromes, cardiac malformations,
             metabolic disorders)

          -  Karnofsky / Lansky score &lt; 50%

          -  subjects unwilling or unable to comply with the study procedures
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christina Peters, Prof. MD PhD</last_name>
    <role>Study Chair</role>
    <affiliation>St. Anna Kinderspital, Vienna, Austria</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Peter Bader, Prof. MD PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Klinik für Kinder- u. Jugendheilkunde III, Johann Wolfgang Goethe Universität, Frankfurt, Germany</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Franco Locatelli, Prof. MD PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Pediatric Hematology and Oncology IRCCS Ospedale, Rome, Italy</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Christina Peters, Prof. MD PhD</last_name>
    <phone>+43140170</phone>
    <phone_ext>3106</phone_ext>
    <email>christina.peters@stanna.at</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Barbara Kristufek</last_name>
    <phone>+43140470</phone>
    <phone_ext>4795</phone_ext>
    <email>barbara.kristufek@ccri.at</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital de Pediatria &quot;Juan P. Garrahan&quot; Combate de Los Pozos N°1800 CABA</name>
      <address>
        <city>Buenos Aires</city>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Raquel Staciuk, MD PhD</last_name>
      <email>rstaciuk@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Raquel Staciuk, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Sor Maria Ludovica, Department Hematology Stem Cell Transplant Unit</name>
      <address>
        <city>La Plata</city>
        <zip>1651</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sergio M Gomez, MD PhD</last_name>
      <email>sergiomgomez_46@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Sergio M Gomez, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Cancer Centre The Royal Children's Hospital</name>
      <address>
        <city>Melbourne</city>
        <zip>3052</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Princess Margaret Hospital for Children</name>
      <address>
        <city>Perth</city>
        <zip>6008</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Sydney Children's Hospital</name>
      <address>
        <city>Randwick</city>
        <zip>2031</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Lady Cilento Children's Hospital</name>
      <address>
        <city>South Brisbane</city>
        <zip>4101</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>The Children`s Hospital at Westmead Oncology Unit</name>
      <address>
        <city>Sydney</city>
        <zip>2145</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitätsklinik für Kinder- und Jugendheilkunde, Abt. f. Hämato-Onkologie</name>
      <address>
        <city>Graz</city>
        <zip>8036</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wolfgang Schwinger, MD PhD</last_name>
      <email>wolfgang.schwinger@medunigraz.at</email>
    </contact>
    <investigator>
      <last_name>Wolfgang Schwinger, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Herwig Lackner, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinik für Kinder- und Jugendheilkunde</name>
      <address>
        <city>Innsbruck</city>
        <zip>6020</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gabriele Kropshofer, MD PhD</last_name>
      <email>gabriele.kropshofer@tirol-kliniken.at</email>
    </contact>
    <investigator>
      <last_name>Gabriele Kropshofer, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bernhard Meister, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Anna Kinderspital</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Herbert Pichler, MD</last_name>
      <email>herbert.pichler@stanna.at</email>
    </contact>
    <contact_backup>
      <last_name>herbert.pichler@stanna.at</last_name>
    </contact_backup>
    <investigator>
      <last_name>Herbert Pichler, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Roswitha Lüftinger, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Elisabeth Salzer, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Belarusian Research Center for Pediatric Oncology, Hematology and Immunology</name>
      <address>
        <city>Minsk</city>
        <country>Belarus</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olga Aleinikova, MD PhD</last_name>
      <email>aleinikova2004@mail.ru</email>
    </contact>
    <investigator>
      <last_name>Olga Aleinikova, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Universitaire des Enfants Reine Fabiola (HUDERF)</name>
      <address>
        <city>Brussels</city>
        <zip>1020</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alina Ferster, MD PhD</last_name>
      <email>alina.ferster@huderf.be</email>
    </contact>
    <investigator>
      <last_name>Alina Ferster, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cliniques Universitaires Saint-Luc (UCL) Hématologie et oncologie pédiatrique</name>
      <address>
        <city>Brussels</city>
        <zip>1200</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Benedicte Brichard, MD PhD</last_name>
      <email>benedicte.brichard@uclouvain.be</email>
    </contact>
    <investigator>
      <last_name>Benedicte Brichard, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Gent Pediatrische hemato-oncologie</name>
      <address>
        <city>Gent</city>
        <zip>9000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Viktoria Bourdon, MD, PhD</last_name>
      <email>vicotria.bordon@uzgent.be</email>
    </contact>
    <investigator>
      <last_name>Viktoria Bourdon, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospitals Leuven Kinderhemato-oncologie</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marleen Renard, MD PhD</last_name>
      <email>marleen.renard@uzleuven.be</email>
    </contact>
    <investigator>
      <last_name>Marleen Renard, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Liège Domaine Universitaire du Sart Tilman</name>
      <address>
        <city>Liège</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marie Françoise Dresse, MD PhD</last_name>
      <email>marie.francoise.dresse@chrcitadelle.be</email>
    </contact>
    <investigator>
      <last_name>Marie Françoise Dresse, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Alberta Children's Hospital Division of Pediatric Oncology</name>
      <address>
        <city>Calgary</city>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tony Truong, MD PhD</last_name>
      <email>truong@albertahealthservices.ca</email>
    </contact>
    <investigator>
      <last_name>Tony Truong, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Victor Lewis, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Montreal Children's Hospital</name>
      <address>
        <city>Montral</city>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Mitchell, MD PhD</last_name>
      <email>david.mitchell@muhc.mcgill.ca</email>
    </contact>
    <investigator>
      <last_name>David Mitchell, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Sainte-Justine Hematology-Oncology Division</name>
      <address>
        <city>Montreal</city>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Henrique Bittencourt, MD PhD</last_name>
      <email>henrique.bittencourt.hsj@ssss.gouv.qc.ca</email>
    </contact>
    <investigator>
      <last_name>Henrique Bittencourt, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital for Sick Children University of Toronto Division of Haematology/Oncology</name>
      <address>
        <city>Toronto</city>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Donna Wall, MD PhD</last_name>
      <email>donna.wall@sickkids.ca</email>
    </contact>
    <investigator>
      <last_name>Donna Wall, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>BC Children's Hospital</name>
      <address>
        <city>Vancouver</city>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Kirk Schultz, MD PhD</last_name>
      <email>kschultz@mail.ubc.ca</email>
    </contact>
    <investigator>
      <last_name>Kirk Schultz, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jeffery Davis, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CancerCare Manitoba/University of Manitoba</name>
      <address>
        <city>Winnipeg</city>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Geoff Cuvelier, MD PhD</last_name>
      <email>gcuvelier@cancercare.mb.ca</email>
    </contact>
    <investigator>
      <last_name>Geoff Cuvelier, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Dr Luis Calvo Mackenna</name>
      <address>
        <city>Santiago</city>
        <country>Chile</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julia Palma, MD PhD</last_name>
      <email>jpalmab@vtr.net</email>
    </contact>
    <investigator>
      <last_name>Julia Palma, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department of Pediatrics, UHC Zagreb</name>
      <address>
        <city>Zagreb</city>
        <country>Croatia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ernest Bilic, MD PhD</last_name>
    </contact>
    <contact_backup>
      <last_name>Toni Matic, MD PhD</last_name>
      <email>madtmatic@yahoo.com</email>
    </contact_backup>
    <investigator>
      <last_name>Ernest Bilic, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Toni Matic, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department of Pediatric Hematology and Oncology Teaching Hospital Motol, 2nd Medical School, Charles University</name>
      <address>
        <city>Prague</city>
        <zip>150 06</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Petr Sedlacek, MD PhD</last_name>
      <email>petr.sedlacek@fnmotol.cz</email>
    </contact>
    <investigator>
      <last_name>Petr Sedlacek, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Petr Riha, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Renata Formankova, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Petra Keslova, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jan Stary, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Paediatric Stem Cell Transplant and Immune Deficiency, Dept. for children and adolescents 4072, Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marianne Ifversen, MD PhD</last_name>
      <email>ifversen@rh.regionh.dk</email>
    </contact>
    <investigator>
      <last_name>Marianne Ifversen, MD PHD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Carsten Heilmann, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Division of Hematology-Oncology and Stem Cell Transplantation, Hospital for Children and Adolescents, Univ. of Helsinki</name>
      <address>
        <city>Helsinki</city>
        <zip>00029 HUS</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kim Vettenranta, MD PhD</last_name>
      <email>kim.vettenranta@hus.fi</email>
    </contact>
    <investigator>
      <last_name>Kim Vettenranta, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Bordeaux</name>
      <address>
        <city>Bordeaux</city>
        <zip>33076</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Charlotte Jubert, MD PhD</last_name>
      <email>charlotte.jubert@chu-bordeaux.fr</email>
    </contact>
    <investigator>
      <last_name>Charlotte Jubert, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Clermont-Ferrand</name>
      <address>
        <city>Clermont-Ferrand</city>
        <zip>63003</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Justyna Kanold, MD PhD</last_name>
      <email>jkanold@chu-clermontferrand.fr</email>
    </contact>
    <investigator>
      <last_name>Justyna Kanold, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Grenoble - Clinique Universitaire de Pédiatrie, Hôpital Couple Enfant</name>
      <address>
        <city>Grenoble</city>
        <zip>38043</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dominique Plantaz, MD PhD</last_name>
      <email>DPlantaz@chu-grenoble.fr</email>
    </contact>
    <investigator>
      <last_name>Dominique Plantaz, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHRU Lille, Service d'Hématologie Pédiatrique</name>
      <address>
        <city>Lille</city>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Benedicte Bruno, MD PhD</last_name>
      <email>benedicte.bruno@chu-lille.fr</email>
    </contact>
    <investigator>
      <last_name>Benedicte Bruno, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IHOP / Lyon, Service Hématologie et d'Oncologie pédiatrique</name>
      <address>
        <city>Lyon</city>
        <zip>69372</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yves Bertrand, MD PhD</last_name>
      <email>yves.bertrand@chu-lyon.fr</email>
    </contact>
    <investigator>
      <last_name>Yves Bertrand, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital la Timone Adulte</name>
      <address>
        <city>Marseille</city>
        <zip>13385</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gerard Michel, MD PhD</last_name>
      <email>gmichel@ap-hm.fr</email>
    </contact>
    <investigator>
      <last_name>Gerard Michel, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital Arnaud de Villeneuve</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne Sirvent, MD PhD</last_name>
      <email>a-sirvent@chu-monpellier.fr</email>
    </contact>
    <investigator>
      <last_name>Anne Sirvent, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Nancy - Hopital d'Enfants</name>
      <address>
        <city>Nancy</city>
        <zip>54500</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cécile Pochon, MD PhD</last_name>
      <email>c.pochon@chu-nancy.fr</email>
    </contact>
    <investigator>
      <last_name>Cécile Pochon, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Nantes, Service d'onco hémato pédiatrie</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fanny Rialland, MD PhD</last_name>
      <email>fanny.rialland@chu-nantes.fr</email>
    </contact>
    <investigator>
      <last_name>Fanny Rialland, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Robert Debré</name>
      <address>
        <city>Paris</city>
        <zip>75019</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>JH Dalle, MD PhD</last_name>
      <email>jhugues.dalle@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Jean-Hugues Dalle, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Rennes, Serive d'Onco-Pédiatrie</name>
      <address>
        <city>Rennes</city>
        <zip>35203</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Virginie Gandemer, MD PhD</last_name>
      <email>virgine.gandemer@chu-rennes.fr</email>
    </contact>
    <investigator>
      <last_name>Virginie Gandemer, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Rouen, Hopital des Enfants, Service d' Immuno-Hématologie Oncologie Pédiatrique</name>
      <address>
        <city>Rouen</city>
        <zip>76031</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pascale Schneider, MD PhD</last_name>
      <email>pascale.schneider@chu-rouen.fr</email>
    </contact>
    <investigator>
      <last_name>Pascale Schneider, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Strasbourg, Service d'hématologie et d'oncologie pédiatrique</name>
      <address>
        <city>Strasbourg</city>
        <zip>67098</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Catherine Paillard, MD PhD</last_name>
      <email>catherine.paillard@chru-strasbourg.fr</email>
    </contact>
    <investigator>
      <last_name>Catherine Paillard, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Uniklinik RWTH Aachen, Kinder- und Jugendmedizin</name>
      <address>
        <city>Aachen</city>
        <zip>52074</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Udo Kontny, MD PhD</last_name>
      <email>ukontny@ukaachen.de</email>
    </contact>
    <investigator>
      <last_name>Udo Kontny, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Olga Moser, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Charité - Universitätsmedizin Berlin, Campus Virchow-Klinikum</name>
      <address>
        <city>Berlin</city>
        <zip>13353</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jörn Kühl, MD PhD</last_name>
      <email>joern-sven.kuehl@charite.de</email>
    </contact>
    <investigator>
      <last_name>Jörn Kühl, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hedwig Deubzer, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Bonn, Abteilung für Pädiatrische Hämatologie und Onkologie</name>
      <address>
        <city>Bonn</city>
        <zip>53113</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dagmar Dilloo, MD PhD</last_name>
      <email>dagmar.dilloo@ukb.uni-bonn.de</email>
    </contact>
    <investigator>
      <last_name>Dagmar Dilloo, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stefan Schönberger, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Düsseldorf, Klinik für Kinder-Onkologie, -Hämatologie und Klinische Immunologie</name>
      <address>
        <city>Düsseldorf</city>
        <zip>40225</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roland Meisel, MD PhD</last_name>
      <email>meisel@med.uni-duesseldorf.de</email>
    </contact>
    <investigator>
      <last_name>Roland Meisel, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Friedhelm Schuster, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Erlangen, Kinder- und Jugendklinik</name>
      <address>
        <city>Erlangen</city>
        <zip>1054</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniel Stachel, MD PhD</last_name>
      <email>daniel.stachel@uk-erlangen.de</email>
    </contact>
    <investigator>
      <last_name>Daniel Stachel, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Markus Metzler, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Essen, Klinik für Kinderheilkunde III</name>
      <address>
        <city>Essen</city>
        <zip>45122</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bernhard Kremens, MD PhD</last_name>
      <email>bernhard.kremens@uk-essen.de</email>
    </contact>
    <investigator>
      <last_name>Bernhard Kremens, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Oliver Basu, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinikum der Johann Wolfgang Goethe-Universität, Klinik für Kinder- und Jugendmedizin (KKJM)</name>
      <address>
        <city>Frankfurt am Main</city>
        <zip>60590</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Bader, MD PhD</last_name>
      <email>peter.bader@kgu.de</email>
    </contact>
    <investigator>
      <last_name>Peter Bader, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jan Soerensen, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Freiburg, Zentrum für Kinder- und Jugendmedizin</name>
      <address>
        <city>Freiburg</city>
        <zip>79106</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brigitte Strahm, MD PhD</last_name>
      <email>brigitte.strahm@uniklinik-freiburg.de</email>
    </contact>
    <investigator>
      <last_name>Brigitte Strahm, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Charlotte Niemeyer, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Gießen, Zentrum für Kinder- und Jugendmedizin</name>
      <address>
        <city>Gießen</city>
        <zip>35392</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wilhelm Wössmann, MD PhD</last_name>
      <email>wilhelm.woessmann@paediat.med.uni-giessen.de</email>
    </contact>
    <contact_backup>
      <last_name>Holger Hauch, MD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Wilhelm Wössmann, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alfred Reiter, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Holger Hauch, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsmedizin Greifswald, Klinik und Poliklinik für Kinder- und Jugendmedizin</name>
      <address>
        <city>Greifswald</city>
        <zip>17475</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Holger Lode, MD PhD</last_name>
      <email>lode@uni-greifswald.de</email>
    </contact>
    <investigator>
      <last_name>Holger Lohde, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Silke Kietz, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Halle (Saale), Universitätsklinik und Poliklinik für Kinder- und Jugendmedizin</name>
      <address>
        <city>Halle</city>
        <zip>06120</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Toralf Bernig, MD PhD</last_name>
      <email>toralf.bernig@uk-halle.de</email>
    </contact>
    <investigator>
      <last_name>Toralf Bernig, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Caspar Kühnöl, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Hamburg-Eppendorf, Klinik und Poliklinik für Pädiatrische Hämatologie und Onkologie</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Johanna Schrum, MD PhD</last_name>
      <email>schrum@uke.uni-hamburg.de</email>
    </contact>
    <investigator>
      <last_name>Johanna Schrum, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ingo Müller, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medizinische Hochschule Hannover, Zentrum Kinderheilkunde und Jugendmedizin</name>
      <address>
        <city>Hannover</city>
        <zip>30625</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karl-Walter Sykora, MD PhD</last_name>
      <email>sykora.karl-walter@mh-hannover.de</email>
    </contact>
    <investigator>
      <last_name>Karl-Walter Sykora, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Martin Sauer, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Heidelberg, Zentrum für Kinder- und Jugendmedizin</name>
      <address>
        <city>Heidelberg</city>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Johann Greil, MD PhD</last_name>
      <email>johann.greil@med.uni-heidelberg.de</email>
    </contact>
    <investigator>
      <last_name>Johann Greil, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Joachim Kunz, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Jena, Sektion für Stammzelltransplantation</name>
      <address>
        <city>Jena</city>
        <zip>07745</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bernd Gruhn, MD PhD</last_name>
      <email>bernd.gruhn@med.uni-jena.de</email>
    </contact>
    <investigator>
      <last_name>Bernd Gruhn, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Karim Kentouche, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UKSH - Universitätsklinikum Schleswig-Holstein, Klinik für Allgemeine Pädiatrie</name>
      <address>
        <city>Kiel</city>
        <zip>24105</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gunnar Cario, MD PhD</last_name>
      <email>g.cario@pediatrics.uni-kiel.de</email>
    </contact>
    <investigator>
      <last_name>Gunnar Cario, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alexander Claviez, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsmedizin Leipzig, Abteilung für Pädiatrische Onkologie, Hämatologie und Hämostaseologie</name>
      <address>
        <city>Leipzig</city>
        <zip>04103</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Holger Christiansen, MD PhD</last_name>
      <email>holger.christiansen@medizin.uni-leipzig.de</email>
    </contact>
    <investigator>
      <last_name>Holger Christiansen, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lars Fischer, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinikum der Universität München, Dr. von Haunersches Kinderspital</name>
      <address>
        <city>München</city>
        <zip>80337</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Albert, MD PhD</last_name>
      <email>michael.albert@med.uni-muenchen.de</email>
    </contact>
    <investigator>
      <last_name>Michael Albert, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tobias Feuchtinger, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Städt. Krankenhaus München Schwabing, Universitätskinderklinik der TU München</name>
      <address>
        <city>München</city>
        <zip>80804</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Irene Teichert- von Lüttichau, MD PhD</last_name>
      <email>irene.teichert-luettichau@lrz.tu-muenchen.de</email>
    </contact>
    <investigator>
      <last_name>Irene Teichert- von Lüttichau, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Angela Wawer, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Münster, Klinik für Kinder- und Jugendmedizin</name>
      <address>
        <city>Münster</city>
        <zip>48149</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claudia Rössig, MD PhD</last_name>
      <email>rossig@uni-muenster.de</email>
    </contact>
    <investigator>
      <last_name>Claudia Rössig, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Birgit Burkhardt, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Regensburg, Klinik und Poliklinik für Kinder- und Jugendmedizin</name>
      <address>
        <city>Regensburg</city>
        <zip>93053</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Selim Corbacioglu, MD PhD</last_name>
      <email>selim.corbacioglu@ukr.de</email>
    </contact>
    <investigator>
      <last_name>Selim Corbacioglu, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jürgen Föll, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinik für Kinder- und Jugendmedizin Tübingen</name>
      <address>
        <city>Tübingen</city>
        <zip>72076</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Lang, MD PhD</last_name>
      <email>peter.lang@med.uni-tuebingen.de</email>
    </contact>
    <investigator>
      <last_name>Peter Lang, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Ulm, Klinik für Kinder- und Jugendmedizin</name>
      <address>
        <city>Ulm</city>
        <zip>89075</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ansgar Schulz, MD PhD</last_name>
      <email>ansgar.schulz@uniklinik-ulm.de</email>
    </contact>
    <investigator>
      <last_name>Ansgar Schulz, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Manfred Hönig, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitäts-Kinderklinik Würzburg</name>
      <address>
        <city>Würzburg</city>
        <zip>97080</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paul-Gerhardt Schlegel, MD PhD</last_name>
      <email>schlegel_p@klinik.uni-wuerzburg.de</email>
    </contact>
    <investigator>
      <last_name>Paul-Gerhardt Schlegel, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Matthias Eyrich, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Saint Sophia Children's Hospital BMT Unit</name>
      <address>
        <city>Athens</city>
        <zip>11527</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vasiliki Kitra-Roussou, MD PhD</last_name>
      <email>vkitra@hotmail.co.uk</email>
    </contact>
    <investigator>
      <last_name>Vasiliki Kitra-Roussou, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anna Paisiou, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dikaia-Eleni Ionnidou, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>George Vessalas, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital of Southern Pest, National Insitute of Hematology and Infectious DiseaseHospital of Southern Pest, National Insitute of Hematology and Infectious Disease Pediatric Bone Marrow Transplantation Unit at Central</name>
      <address>
        <city>Budapest</city>
        <zip>1097</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gergely Krivan, MD PhD</last_name>
      <email>krivang@hu.inter.net</email>
    </contact>
    <investigator>
      <last_name>Gergely Krivan, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Krisztián Kallay, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rambam Medical Center</name>
      <address>
        <city>Haifa</city>
        <zip>31096</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roni Gefen, MD PhD</last_name>
      <email>r_gefen@rambam.health.gov.il</email>
    </contact>
    <investigator>
      <last_name>Roni Gefen, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Schneider Children`s Medical Center of Israel</name>
      <address>
        <city>Petach-Tikva</city>
        <zip>49202</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jerry Stein, MD PhD</last_name>
      <email>jstein@clalit.org.il</email>
    </contact>
    <investigator>
      <last_name>Jerry Stein, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dana Children's Hospital</name>
      <address>
        <city>Tel Aviv</city>
        <zip>64239</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ronit Elhasid, MD PhD</last_name>
      <email>ronite@tasmc.health.go.il</email>
    </contact>
    <investigator>
      <last_name>Ronit Elhasid, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliero-Universitaria Policlinico S. Orsola-Malpighi di Bologna</name>
      <address>
        <city>Bologna</city>
        <zip>40138</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Prete Arcangelo, MD PhD</last_name>
      <email>tmoped@aosp.bo.it</email>
    </contact>
    <investigator>
      <last_name>Prete Arcangelo, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Mayer di Firenze SODc Tumori Pediatrici e TMO</name>
      <address>
        <city>Florence</city>
        <zip>50139</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Veronica Tintori, MD PhD</last_name>
      <email>v.tintori@meyer.it</email>
    </contact>
    <investigator>
      <last_name>Veronica Tintori, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Istituto Gaslini Genova Oncoematologia Pediatrica-</name>
      <address>
        <city>Genoa</city>
        <zip>16147</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Edoardo Lanino, MD PhD</last_name>
      <email>edoardolanino@gaslini.org</email>
    </contact>
    <investigator>
      <last_name>Edoardo Lanino, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>A.O. San Gerardo di Monza Clinica Pediatrica</name>
      <address>
        <city>Monza</city>
        <zip>20900</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Adriana Balduzzi, MD PhD</last_name>
      <email>a.balduzzi@hsgerardo.org</email>
    </contact>
    <investigator>
      <last_name>Adriana Balduzzi, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>A.O.R.N. Santobono Pausilipon, Dipartimento di Oncoematologia</name>
      <address>
        <city>Napoli</city>
        <zip>80123</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Francesco Paolo Tambaro, MD</last_name>
      <email>fp.tambaro@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Francesco Paolo Tambaro, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera di Padova Oncoematologia Pediatrica</name>
      <address>
        <city>Padova</city>
        <zip>35128</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Alessandra Biffi, MD PhD</last_name>
      <email>alessandra.biffi@unipd.it</email>
    </contact>
    <investigator>
      <last_name>Alessandra Biffi, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fondazione IRCCS Policlinico San Matteo</name>
      <address>
        <city>Pavia</city>
        <zip>27100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mario Zecca, MD PhD</last_name>
      <email>m.zecca@smatteo.pv.it</email>
    </contact>
    <investigator>
      <last_name>Mario Zecca, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliero Universitaria Pisana U.O. di Oncoematologia Pediatrica A.O.</name>
      <address>
        <city>Pisa</city>
        <zip>56126</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Gabriella Casazza, MD PhD</last_name>
      <email>g.casazza@libero.it</email>
    </contact>
    <investigator>
      <last_name>Gabriella Casazza, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Pediatrico Bambino Gesù</name>
      <address>
        <city>Rome</city>
        <zip>00165</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Franco Locatelli, MD PhD</last_name>
      <email>franco.locatelli@opbg.net</email>
    </contact>
    <investigator>
      <last_name>Franco Locatelli, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Infantile Regina Margherita SC Oncoematologia e Centro Trapianti</name>
      <address>
        <city>Torino</city>
        <zip>10126</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Franca Fagioli, MD PhD</last_name>
      <email>franca.fagioli@unito.it</email>
    </contact>
    <investigator>
      <last_name>Franca Fagioli, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Malaya, Department of Paediatrics</name>
      <address>
        <city>Kuala Lumpur</city>
        <country>Malaysia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hany Ariffin, MD PhD</last_name>
      <email>hany@ummc.edu.my</email>
    </contact>
    <investigator>
      <last_name>Hany Ariffin, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Instituto Nacional de Peditria</name>
      <address>
        <city>Ciudad de México</city>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alberto Olaya Vargas, MD PhD</last_name>
      <email>alberto.olaya@yahoo.com.mx</email>
    </contact>
    <investigator>
      <last_name>Alberto Olaya Vargas, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Leiden University Medical Center Department of Pediatrics/BMT unit</name>
      <address>
        <city>Leiden</city>
        <zip>2300</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Arjan Lankester, MD PhD</last_name>
    </contact>
    <contact_backup>
      <email>A.Lankester@lumc.nl</email>
    </contact_backup>
    <investigator>
      <last_name>Arjan Lankester, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Princess Máxima Center for Pediatric Oncology</name>
      <address>
        <city>Utrecht</city>
        <zip>3584</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marc Bierings, MD PhD</last_name>
      <email>M.Bierings@prinsesmaximacentrum.nl</email>
    </contact>
    <investigator>
      <last_name>Marc Bierings, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Starship Children's Hospital</name>
      <address>
        <city>Auckland</city>
        <zip>1142</zip>
        <country>New Zealand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lochie Teague, MD PhD</last_name>
      <email>lochiet@adhb.govt.nz</email>
    </contact>
    <investigator>
      <last_name>Lochie Teague, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Oslo University Hospital Rikshospitalet</name>
      <address>
        <city>Oslo</city>
        <zip>0424</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jochen Büchner, MD PhD</last_name>
      <email>jocbuc@ous-hf.no</email>
    </contact>
    <investigator>
      <last_name>Jochen Büchner, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital No.1, Collegium Medicum UMK, department of Paediatrics, Oncology, Hematology and Paediatric Transplantology</name>
      <address>
        <city>Bydgoszcz</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mariusz Wysocki, MD PhD</last_name>
      <email>tsk@cm.umk.pl</email>
    </contact>
    <investigator>
      <last_name>Mariusz Wysocki, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Children`s Hospital in Krakow, Department of Transplantation</name>
      <address>
        <city>Kraków</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jolanta Gozdzik, MD PhD</last_name>
      <email>jgozdzik@cm-uj.krakow.pl</email>
    </contact>
    <investigator>
      <last_name>Jolanta Gozdzik, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children`s University Hospital, Dept. Pediatric Hematology, Oncology, and Transplantology</name>
      <address>
        <city>Lublin</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jerzy R. Kowalczyk, MD</last_name>
      <email>jerzy.kowalczyk@dsk.lublin.pl</email>
    </contact>
    <investigator>
      <last_name>Jerzy R. Kowalczyk, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Poznan University of Medical Sciences, Department of Pediatric Onology, Hematology &amp; HSCT</name>
      <address>
        <city>Poznań</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jacek Wachowiak, MD PhD</last_name>
      <email>jacek.wachowiak@plusnet.pl</email>
    </contact>
    <investigator>
      <last_name>Jacek Wachowiak, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cape of Hope, Wroclaw Medical University</name>
      <address>
        <city>Wrocław</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alicja Chybicka, MD PhD</last_name>
      <email>alicjachybicka@wp.pl</email>
    </contact>
    <investigator>
      <last_name>Alicja Chybicka, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IInsitutul Clinic Fundeni, Sectia de Transplant Medular</name>
      <address>
        <city>Bukarest</city>
        <country>Romania</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anca Colita, MD PhD</last_name>
      <email>ancacolita@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Anca Colita, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Medicine and Pharmacy V. BABES, Emergency Children's Hospital LOUIS TURCANU, III. Clinic of Pediatrics , Department of Onco-hematology and Bone Marrow Transplantation</name>
      <address>
        <city>Timişoara</city>
        <country>Romania</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cristian Jinca, MD PhD</last_name>
      <email>cristian_jinca@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Cristian Jinca, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>King Abdullah specialists children hospital</name>
      <address>
        <city>Riyadh</city>
        <country>Saudi Arabia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mohammed Essa, MD PhD</last_name>
      <email>essamo@ngha.med.sa</email>
    </contact>
    <investigator>
      <last_name>Mohammed Essa, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Children's Hospital</name>
      <address>
        <city>Bratislava</city>
        <zip>83340</zip>
        <country>Slovakia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Svec, MD PhD</last_name>
      <email>peter.svec@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Peter Svec, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dominika Tanuskova, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University childrens' hospital, UMCL</name>
      <address>
        <city>Ljubljana</city>
        <country>Slovenia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Vladan Rajic, MD PhD</last_name>
      <email>vladan.rajic.avcin@kclj.si</email>
    </contact>
    <investigator>
      <last_name>Vladan Rajic, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Santa Creu i Sant Pau</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luisa Sisini, MD</last_name>
      <email>LSisinni@santpau.cat</email>
    </contact>
    <investigator>
      <last_name>Luisa Sisini, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Vall d'Hebron</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cristina Díaz de Heredia, MD</last_name>
      <email>crdiaz@vhebron.net</email>
    </contact>
    <investigator>
      <last_name>Cristina Díaz de Heredia, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Virgen de la Arrixaca</name>
      <address>
        <city>El Palmar</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>José Luis Fuster, MD</last_name>
      <email>josel.fuster@carm.es</email>
    </contact>
    <investigator>
      <last_name>José Luis Fuster, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Materno Infantil de Málaga</name>
      <address>
        <city>Málaga</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Antonia Pascual, MD</last_name>
      <email>pascualmartinez5@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Antonia Pascual, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Central de Asturias</name>
      <address>
        <city>Oviedo</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pilar Palomo, MD</last_name>
      <email>pilarpalomo@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Pilar Palomo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Queen Silvia Children's Hospital, Department of Pediatric Oncology (Avdelnig 321-322)</name>
      <address>
        <city>Göteborg</city>
        <zip>41685</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karin Mellgren, MD PhD</last_name>
      <email>karin.mellgren@vgregion.se</email>
    </contact>
    <investigator>
      <last_name>Karin Mellgren, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Skane University Hospital, Dept. of Pediatrics, Section for Hematology and Oncology</name>
      <address>
        <city>Lund</city>
        <zip>22185</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jacek Toporski, MD PhD</last_name>
      <email>jacek.toporski@skane.se</email>
    </contact>
    <investigator>
      <last_name>Jacek Toporski, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Karolinska University Hospital, Department of Pediatrics</name>
      <address>
        <city>Stockholm</city>
        <zip>14186</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jacek Winiaarski, MD PhD</last_name>
      <email>jacek.winiarski@ki.se</email>
    </contact>
    <investigator>
      <last_name>Jacek Winiarski, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Children's Hospital, Dept. of Women's &amp; Children's Health Section for Pediatrics</name>
      <address>
        <city>Uppsala</city>
        <zip>75185</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Natalja Jackman, MD PhD</last_name>
      <email>natalja.jackman@akademiska.se</email>
    </contact>
    <investigator>
      <last_name>Natalja Jackman, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitäts-Kinderspital beider Basel (UKBB)</name>
      <address>
        <city>Basel</city>
        <zip>4056</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicolas Von der Weid, MD PhD</last_name>
      <email>nicolas.vonderweid@ukbb.ch</email>
    </contact>
    <investigator>
      <last_name>Nicolas Von der Weid, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>HUG Hôpitaux Universitaire de Genève</name>
      <address>
        <city>Geneva</city>
        <zip>1211</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marc Ansari, MD PhD</last_name>
      <email>Marc.Ansari@hcuge.ch</email>
    </contact>
    <investigator>
      <last_name>Marc Ansari, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitäts-Kinderspital Zurich</name>
      <address>
        <city>Zurich</city>
        <zip>8032</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Güngör Tayfun, MD PhD</last_name>
      <email>tayfun.guengoer@kispi.uzh.ch</email>
    </contact>
    <investigator>
      <last_name>Güngör Tayfun, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ankara University School of Medicine Pediatric Stem Cell Transplantation Unit</name>
      <address>
        <city>Ankara</city>
        <zip>06100</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mehmet Ertem, MD PhD</last_name>
    </contact>
    <contact_backup>
      <last_name>Elif Ince, MD</last_name>
      <email>elifunal@msn.com</email>
    </contact_backup>
    <investigator>
      <last_name>Mehmet Ertem, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Elif Ince, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gazi University School of Medicine Pediatric Stem Cell Transplantation Unit</name>
      <address>
        <city>Ankara</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ulker Kocak, MD PhD</last_name>
      <email>ulkerkocak@gazi.edu.tr</email>
    </contact>
    <investigator>
      <last_name>Ulker Kocak, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gülhane Training and Research Hospital</name>
      <address>
        <city>Ankara</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Orhan Gursel, MD PhD</last_name>
      <email>orhan.gursel@sbu.edu.tr</email>
    </contact>
    <investigator>
      <last_name>Orhan Gursel, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Akdeniz University School of Medicine Pediatric Stem Cell Transplantation Unit</name>
      <address>
        <city>Antalya</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alphan Kupesiz, MD PhD</last_name>
      <email>akupesiz@akdeniz.edu.tr</email>
    </contact>
    <investigator>
      <last_name>Alphan Kupesiz, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bahcesehir University School of Medicine Pediatric Stem Cell Transplantation Unit</name>
      <address>
        <city>Antalya</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Akif Yesilipek, MD PhD</last_name>
      <email>yesilipek@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Akif Yesilipek, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Acibadem University Atakent Hospital Pediatric Stem Cell Transplantation Unit</name>
      <address>
        <city>Istanbul</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gulyuz Ozturk, MD PhD</last_name>
      <email>gulyuzo@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Gulyuz Ozturk, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Didem Atay, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bahcelievler Medicalpark Hospital Pediatric Stem Cell Transplantation Unit</name>
      <address>
        <city>Istanbul</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tunc Fisgin, MD PhD</last_name>
      <email>Tunc.fisgin@medicalparc.com.tr</email>
    </contact>
    <investigator>
      <last_name>Tunc Fisgin, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bahcesehir University School of Medicine Pediatric Stem Cell Transplantation Unit</name>
      <address>
        <city>Istanbul</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gulsun Karasu, MD PhD</last_name>
      <email>gulsuntezcan@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Gulsun Karasu, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Suar Kilic, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medipol Mega Üniversite Hastanesi</name>
      <address>
        <city>Istanbul</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sema Anak, MD PhD</last_name>
      <email>sanak@medipol.edu.tr</email>
    </contact>
    <investigator>
      <last_name>Sema Anak, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yöntem Yaman, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dokuzeylul University School of Medicine Pediatric Stem Cell Transplantation Unit</name>
      <address>
        <city>Izmir</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hale Oren, MD PhD</last_name>
      <email>hale.oren@deu.edu.tr</email>
    </contact>
    <investigator>
      <last_name>Hale Oren, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sebnem Yilmaz, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ege University School of Medicine Pediatric Stem Cell Transplantation Unit</name>
      <address>
        <city>Izmir</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Savaş Kansoy, MD PhD</last_name>
      <email>savas.kansoy@ege.edu.tr</email>
    </contact>
    <investigator>
      <last_name>Savaş Kansoy, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Serap Aksoylar, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Erciyes University School of Medicine Pediatric Stem Cell Transplantation Unit</name>
      <address>
        <city>Kayseri</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Musa Karakukcu, MD PhD</last_name>
      <email>mkkukcu@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Musa Karakukcu, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ekrem Unal, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Argentina</country>
    <country>Australia</country>
    <country>Austria</country>
    <country>Belarus</country>
    <country>Belgium</country>
    <country>Canada</country>
    <country>Chile</country>
    <country>Croatia</country>
    <country>Czechia</country>
    <country>Denmark</country>
    <country>Finland</country>
    <country>France</country>
    <country>Germany</country>
    <country>Greece</country>
    <country>Hungary</country>
    <country>Israel</country>
    <country>Italy</country>
    <country>Malaysia</country>
    <country>Mexico</country>
    <country>Netherlands</country>
    <country>New Zealand</country>
    <country>Norway</country>
    <country>Poland</country>
    <country>Romania</country>
    <country>Saudi Arabia</country>
    <country>Slovakia</country>
    <country>Slovenia</country>
    <country>Spain</country>
    <country>Sweden</country>
    <country>Switzerland</country>
    <country>Turkey</country>
  </location_countries>
  <removed_countries>
    <country>Czech Republic</country>
  </removed_countries>
  <link>
    <url>https://kinderkrebsforschung.at/</url>
    <description>St. Anna Kinderkrebsforschung</description>
  </link>
  <link>
    <url>https://www.stanna.at/</url>
    <description>St. Anna Kinderspital</description>
  </link>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>September 9, 2013</study_first_submitted>
  <study_first_submitted_qc>September 19, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 24, 2013</study_first_posted>
  <last_update_submitted>June 26, 2019</last_update_submitted>
  <last_update_submitted_qc>June 26, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 28, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>St. Anna Kinderkrebsforschung</investigator_affiliation>
    <investigator_full_name>Prof. Christina Peters</investigator_full_name>
    <investigator_title>Univ.-Prof. Dr. Christina Peters</investigator_title>
  </responsible_party>
  <keyword>stem cell transplantation</keyword>
  <keyword>children and adolescents</keyword>
  <keyword>high risk acute lymphoblastic leukaemia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Leukemia</mesh_term>
    <mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
    <mesh_term>Leukemia, Lymphoid</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cyclophosphamide</mesh_term>
    <mesh_term>Busulfan</mesh_term>
    <mesh_term>Thiotepa</mesh_term>
    <mesh_term>Treosulfan</mesh_term>
    <mesh_term>Fludarabine</mesh_term>
    <mesh_term>Etoposide</mesh_term>
    <mesh_term>Thymoglobulin</mesh_term>
    <mesh_term>Antilymphocyte Serum</mesh_term>
    <mesh_term>Immunoglobulins</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

